The leaves of the Ginkgo biloba tree have been recognized in China for centuries for their beneficial effects.
The very special extract of Ginkgo biloba prepared according to Dr. Mirko Beljanski’s extraction procedure is completely different from all green extracts of this plant that one may find on the market. Due to the time at which these leaves are harvested and due to the very particular extraction procedure, Ginkgo V® differs in nature and acts in a completely different way from classical standardized Ginkgo extracts.1,2
Professor Beljanski demonstrated in multiple experiments that his original Gingko extract acts as a regulator of cell enzymes called ribonucleases.3* In a healthy cell, the normal function of these enzymes is to trim and finalize the messages copied from the DNA, a process that is essential for overall health in the human body. In some conditions of extreme physical stress, these enzymes can become deregulated (or disrupted). Ultimately, this can have a damaging effect on the health of cells and bodily tissues.
Ginkgo V®, through its regulatory or normalizing effect on cellular enzymes, enhances the natural cell repair process and helps the tissues to remain healthy, even when they are exposed to extreme physiological stresses. 3*
Contents: 100 capsules per bottle. Each capsule of Ginkgo V® contains powdered golden leaf ginkgo extract.
Suggested Daily Intake as a Dietary Supplement: Take up to 10 capsules per day with a glass of water or as recommended by your health care practitioner.
From our laboratories to your hands, quality control standards are continuously applied to assure you a product worthy of the Beljanski® name and reputation.
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
1M. BELJANSKI, “The Regulation of DNA Replication and Transcription.” 3rd ed. demosMEDICAL, New York, NY, 2013, pp. 1-190.
2C. NORDAU, M. BELJANSKI, “A Pioneer in Biomedicine”, Evi Liberty Corp, New York, 2000, p. 118.
3J.E. CAUSSE, T. NAWROCKI, M. BELJANSKI, "Human Skin Fibrosis RNase Search for a Biological Inhibitor-Regulator". Deutsche Zeitschrift für Onkologie, 26, 5, 1994, pp. 137-139.